TargetMol

Ciprofloxacin EP IMpurity A

Product Code:
 
TAR-T1733
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T1733-1mL1 mL * 10 mM (in DMSO)£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1733-500mg500mg£130.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Fluoroquinolonic Acid is an antibiotic and antimicrobial agent.
CAS:
86393-33-1
Formula:
C13H9ClFNO3
Molecular Weight:
281.67
Pathway:
Microbiology/Virology
Purity:
0.9744
SMILES:
OC(=O)c1cn(C2CC2)c2cc(Cl)c(F)cc2c1=O
Target:
Antibiotic

References

1. Trefi, S., Gilard, V., Malet-Martino, M., & Martino, R. (2007). Generic ciprofloxacin tablets contain the stated amount of drug and different impurity profiles: A 19F, 1H and DOSY NMR analysis.?Journal Of Pharmaceutical And Biomedical Analysis,?44(3), 743-754. doi: 10.1016/j.jpba.2007.02.031 2. Zhi, C., Long, Z., Manikowski, A., Comstock, J., Xu, W., & Brown, N. et al. (2006). Hybrid Antibacterials. DNA Polymerase?Topoisomerase Inhibitors.?Journal Of Medicinal Chemistry,?49(4), 1455-1465. doi: 10.1021/jm05120023 3. Siefert, H., Maruhn, D., Maul, W., Forstter, D., & Ritter, W. (1986). Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.?Arzneimittelforschung,?36(10), 1496-502.